期刊文献+

肾癌根治术前肾动脉化疗栓塞的疗效观察 被引量:2

A study of preoperative transarterial chemo-embolization for renal cell carcinoma.
在线阅读 下载PDF
导出
摘要 目的评价根治术前化疗栓塞对肾癌预后的影响.方法对26例经术后病理证实并获随访的肾癌患者临床资料进行回顾性分析,分A、B两组,肾癌根治术前化疗栓塞组16例(A组),单纯根治术组10例(B)组.A组经肾动脉灌注化疗药物后,用碘油和化疗药物混合剂行末梢血管栓塞,用明胶海绵进行中心性栓塞,化疗栓塞后2~5d行患肾根治术性切除.结果 A组术中出血量150~500ml,平均220ml;少于B组.A组1、3、5年生存率分别为86.6%、72.7%、58.1%,两组比较,差别均有显著性意义(P<0.05).Cox模型分析表明,根治术前化疗栓塞是影响肾癌预后的独立因素.结论肾癌根治术前化疗栓塞安全有效,对肾癌的治疗有积极意义. Objective To evaluate the prognostic efficacy of preoperative transarterial chemo-embolization for renal cell carcinoma. Methods A total of 26 cases of renal cell carcinoma confirmed by operation and pathology were retrospective studied, 16 cases were allotted to preoperative transarterial chemo-embotization and 10 cases by operation alone. Preperative transarterial chemo-embolizotion was perfomed by infusing anticaner drugs, followed by emnulsion of iodized ail and anticancer drugs for peripneral vessels embolization and then by infeeting gelation sponger into the renal artery.Surgery was perfrmed within 2~5days after transarterial chemo-embolization.Results Preoperative transarterial chemo-embolization made vesection easier. The 1,3,5 year survival of chemo-embolization group was higher than the operation alone group (P<0 05). The Cox model analysis showed preoperative transarterial chemo-embolization was an independent factor affecting the long term survival rate of renal cell carcinoma. Conclusion Preoperative transarterial chemo-embotization is a safe and effective method in the treatment of renal cell carcinoma.
作者 岳文涛 都军
出处 《现代肿瘤医学》 CAS 2005年第1期89-90,共2页 Journal of Modern Oncology
关键词 肾肿瘤 化学栓塞 renal carcionoma chemo-embolism
  • 相关文献

参考文献4

二级参考文献2

  • 1石梅海,临床泌尿外科杂志,1991年,6期,68页
  • 2石腾骧,中华泌尿外科杂志,1986年,7卷,41页

共引文献65

同被引文献19

  • 1井元恒,刘军霞,冀强,闫河峰,卢建路.超选择性肾动脉栓塞化疗术在肾癌治疗中的应用[J].中国煤炭工业医学杂志,2004,7(11):1072-1073. 被引量:5
  • 2吴晶涛,孙丽光,王田蔚,赵永生,杨海山.介入治疗对肾癌微血管密度的影响[J].中国实验诊断学,2005,9(6):967-969. 被引量:15
  • 3方向明,陈宏伟,陆进,徐平,王卫东,许隽颖,蒋兆贯.术前超选择性肾动脉化疗栓塞对小肾癌保肾手术的价值[J].中国癌症杂志,2006,16(4):301-303. 被引量:6
  • 4陈仲武,陈济铭,官怀文,陈一平.中晚期肾癌术前介入治疗的临床价值[J].生物医学工程与临床,2006,10(2):79-81. 被引量:5
  • 5Gitlitz RI,Figlin RB.Cytokine-based therapy for metastatic renal cell cancer[J].Urol Clin North Am,2003,30(3):589.
  • 6Darrel Drachenberg,Richard W,Childs.Allogenic stern cell transplantation as immunotherapy for renal cell carcinoma:from immune enhancement to immune replacement[J].Urol Clin North Am,2003,30(3):611.
  • 7Mosharafa Ashraf,Koch Michael,Shalhav Arieh,et a1.Nephrectomy for metastatic renal cell carcinoma[J].Indiana Univ Exp Urol,2003,62(4):636.
  • 8Fichtner J,Swoboda A.Percutaneous embolization of the kidney:indications and clinical results[J].Aktuelle Urol,2003,34(7):475.
  • 9Osada J,Pietruczuk M,Dabrowska M,et al.An assessment of lymphocytic population in peripheral blood of patients with renal cell carcinoma before and after embolization[J].Rocz Akad Med Bialymst,2000,45:228.
  • 10Singh R,O' Brien T.The role of transarterial embolization in the treatment of renal cell carcinoma[J].BJU Int,2004,93(1):181.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部